The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease
Open accessAbstract
Chikungunya virus (CHIKV) is a re-emerging arbovirus responsible for a massive outbreak currently afflicting the Indian Ocean region and India. Infection from CHIKV typically induces a mild disease in humans, characterized by fever, myalgia, arthralgia, and rash. Cases of severe CHIKV infection involving the central nervous system (CNS) have recently been described in neonates as well as in adults with underlying conditions. The pathophysiology of CHIKV infection and the basis for disease severity are unknown. To address these critical issues, we have developed an animal model of CHIKV infection. We show here that whereas wild type (WT) adult mice are resistant to CHIKV infection, WT mouse neonates are susceptible and neonatal disease severity is age-dependent. Adult mice with a partially (IFN-alpha/betaR(+/-)) or totally (IFN-alpha/betaR(-/-)) abrogated type-I IFN pathway develop a mild or severe infection, respectively. In mice with a mild infection, after a burst of viral replication in the liver, CHIKV primarily targets muscle, joint, and skin fibroblasts, a cell and tissue tropism similar to that observed in biopsy samples of CHIKV-infected humans. In case of severe infections, CHIKV also disseminates to other tissues including the CNS, where it specifically targets the choroid plexuses and the leptomeninges. Together, these data indicate that CHIKV-associated symptoms match viral tissue and cell tropisms, and demonstrate that the fibroblast is a predominant target cell of CHIKV. These data also identify the neonatal phase and inefficient type-I IFN signaling as risk factors for severe CHIKV-associated disease. The development of a permissive small animal model will expedite the testing of future vaccines and therapeutic candidates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Innate immunity of the newborn: basic mechanisms and clinical correlates
Levy, O. (2007) · Nature Reviews Immunology · doi:10.1038/nri2075 · Cited by 1,223
Genome Microevolution of Chikungunya Viruses Causing the Indian Ocean Outbreak
Schuffenecker, I., Iteman, I., Michault, A., Murri, S., Frangeul, L., Vaney, M.-C., Lavenir, R., Pardigon, N., Reynes, J.-M., Pettinelli, F., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030263 · Cited by 1,222
Self-citationChikungunya, an epidemic arbovirosis
Pialoux, G., Gaüzère, B.-A., Jauréguiberry, S., & Strobel, M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70107-x · Cited by 1,129
An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–1953
Robinson, M. C. (1955) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(55)90080-8 · Cited by 995
Borgherini, G., Poubeau, P., Staikowsky, F., Lory, M., Moullec, N. L., Becquart, J. P., Wengling, C., Michault, A., & Paganin, F. (2007) · Clinical Infectious Diseases · doi:10.1086/517537 · Cited by 522
Self-citationGérardin, P., Barau, G., Michault, A., Bintner, M., Randrianaivo, H., Choker, G., Lenglet, Y., Touret, Y., Bouveret, A., Grivard, P., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050060 · Cited by 521
Self-citationCharacterization of Reemerging Chikungunya Virus
Sourisseau, M., Schilte, C., Casartelli, N., Trouillet, C., Guivel-Benhassine, F., Rudnicka, D., Sol-Foulon, N., Roux, K. L., Prevost, M.-C., Fsihi, H., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030089 · Cited by 509
Self-citationChikungunya Outbreaks — The Globalization of Vectorborne Diseases
Charrel, R. N., de Lamballerie, X., & Raoult, D. (2007) · New England Journal of Medicine · doi:10.1056/nejmp078013 · Cited by 459
Vectors of Chikungunya virus in Senegal: current data and transmission cycles.
Diallo, M., Thonnon, J., Traore-Lamizana, M., & Fontenille, D. (1999) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.1999.60.281 · Cited by 423
Cited by
Netland, J., Meyerholz, D. K., Moore, S., Cassell, M., & Perlman, S. (2008) · Journal of Virology · doi:10.1128/jvi.00737-08 · Cited by 1,293
Desforges, M., Le Coupanec, A., Dubeau, P., Bourgouin, A., Lajoie, L., Dubé, M., & Talbot, P. J. (2019) · Viruses · doi:10.3390/v12010014 · Cited by 1,048
Chikungunya Virus and the Global Spread of a Mosquito-Borne Disease
Weaver, S. C., & Lecuit, M. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1406035 · Cited by 986
Self-citationBiology and pathogenesis of chikungunya virus
Schwartz, O., & Albert, M. L. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2368 · Cited by 783
Self-citationIdentification of a candidate therapeutic autophagy-inducing peptide
Shoji-Kawata, S., Sumpter, R., Leveno, M., Campbell, G. R., Zou, Z., Kinch, L., Wilkins, A. D., Sun, Q., Pallauf, K., MacDuff, D., et al. (2013) · Nature · doi:10.1038/nature11866 · Cited by 760
Hoarau, J.-J., Jaffar Bandjee, M.-C., Krejbich Trotot, P., Das, T., Li-Pat-Yuen, G., Dassa, B., Denizot, M., Guichard, E., Ribera, A., Henni, T., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900255 · Cited by 640
Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages
Labadie, K., Larcher, T., Joubert, C., Mannioui, A., Delache, B., Brochard, P., Guigand, L., Dubreil, L., Lebon, P., Verrier, B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40104 · Cited by 589
Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy
Thiberville, S.-D., Moyen, N., Dupuis-Maguiraga, L., Nougairede, A., Gould, E. A., Roques, P., & de Lamballerie, X. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.06.009 · Cited by 561
Gérardin, P., Barau, G., Michault, A., Bintner, M., Randrianaivo, H., Choker, G., Lenglet, Y., Touret, Y., Bouveret, A., Grivard, P., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050060 · Cited by 521
Self-citationAkahata, W., Yang, Z.-Y., Andersen, H., Sun, S., Holdaway, H. A., Kong, W.-P., Lewis, M. G., Higgs, S., Rossmann, M. G., Rao, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2105 · Cited by 515
Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases
Weaver, S. C., Charlier, C., Vasilakis, N., & Lecuit, M. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-050715-105122 · Cited by 501
Self-citationChikungunya Virus-associated Long-term Arthralgia: A 36-month Prospective Longitudinal Study
Schilte, C., Staikovsky, F., Couderc, T., Madec, Y., Carpentier, F., Kassab, S., Albert, M. L., Lecuit, M., & Michault, A. (2013) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002137 · Cited by 498
Self-citationArthritogenic alphaviruses—an overview
Suhrbier, A., Jaffar-Bandjee, M.-C., & Gasque, P. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.64 · Cited by 489
Chikungunya Virus Arthritis in Adult Wild-Type Mice
Gardner, J., Anraku, I., Le, T. T., Larcher, T., Major, L., Roques, P., Schroder, W. A., Higgs, S., & Suhrbier, A. (2010) · Journal of Virology · doi:10.1128/jvi.02603-09 · Cited by 438
Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
Balsitis, S. J., Williams, K. L., Lachica, R., Flores, D., Kyle, J. L., Mehlhop, E., Johnson, S., Diamond, M. S., Beatty, P. R., & Harris, E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000790 · Cited by 412
Chow, A., Her, Z., Ong, E. K. S., Chen, J.-M., Dimatatac, F., Kwek, D. J. C., Barkham, T., Yang, H., Rénia, L., Leo, Y.-S., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq042 · Cited by 389
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
Wu, X., Dao Thi, V. L., Huang, Y., Billerbeck, E., Saha, D., Hoffmann, H.-H., Wang, Y., Silva, L. A. V., Sarbanes, S., Sun, T., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.018 · Cited by 385
Replication cycle of chikungunya: A re-emerging arbovirus
Solignat, M., Gay, B., Higgs, S., Briant, L., & Devaux, C. (2009) · Virology · doi:10.1016/j.virol.2009.07.024 · Cited by 384
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Garland, K. M., Sheehy, T. L., & Wilson, J. T. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00750 · Cited by 357
Type I IFN controls chikungunya virus via its action on nonhematopoietic cells
Schilte, C., Couderc, T., Chretien, F., Sourisseau, M., Gangneux, N., Guivel-Benhassine, F., Kraxner, A., Tschopp, J., Higgs, S., Michault, A., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20090851 · Cited by 326
Self-citationDupuis-Maguiraga, L., Noret, M., Brun, S., Le Grand, R., Gras, G., & Roques, P. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001446 · Cited by 319
IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity
Ng, L. F. P., Chow, A., Sun, Y.-J., Kwek, D. J. C., Lim, P.-L., Dimatatac, F., Ng, L.-C., Ooi, E.-E., Choo, K.-H., Her, Z., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004261 · Cited by 304
Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus
Pal, P., Dowd, K. A., Brien, J. D., Edeling, M. A., Gorlatov, S., Johnson, S., Lee, I., Akahata, W., Nabel, G. J., Richter, M. K. S., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003312 · Cited by 300
Bartholomeeusen, K., Daniel, M., LaBeaud, D. A., Gasque, P., Peeling, R. W., Stephenson, K. E., Ng, L. F. P., & Ariën, K. K. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00429-2 · Cited by 297
A Mouse Model of Chikungunya Virus–Induced Musculoskeletal Inflammatory Disease
Morrison, T. E., Oko, L., Montgomery, S. A., Whitmore, A. C., Lotstein, A. R., Gunn, B. M., Elmore, S. A., & Heise, M. T. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.018 · Cited by 290
Fros, J. J., Liu, W. J., Prow, N. A., Geertsema, C., Ligtenberg, M., Vanlandingham, D. L., Schnettler, E., Vlak, J. M., Suhrbier, A., Khromykh, A. A., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00949-10 · Cited by 284
Wauquier, N., Becquart, P., Nkoghe, D., Padilla, C., Ndjoyi-Mbiguino, A., & Leroy, E. M. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq006 · Cited by 274
Pohjala, L., Utt, A., Varjak, M., Lulla, A., Merits, A., Ahola, T., & Tammela, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028923 · Cited by 270
A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development
de Lima Cavalcanti, T. Y. V., Pereira, M. R., de Paula, S. O., & Franca, R. F. D. O. (2022) · Viruses · doi:10.3390/v14050969 · Cited by 259
Kose, N., Fox, J. M., Sapparapu, G., Bombardi, R., Tennekoon, R. N., de Silva, A. D., Elbashir, S. M., Theisen, M. A., Humphris-Narayanan, E., Ciaramella, G., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw6647 · Cited by 202
Contributions of maternal and fetal antiviral immunity in congenital disease
Yockey, L. J., Lucas, C., & Iwasaki, A. (2020) · Science · doi:10.1126/science.aaz1960 · Cited by 68
Yu, J., Liu, X., Ke, C., Wu, Q., Lu, W., Qin, Z., He, X., Liu, Y., Deng, J., Xu, S., et al. (2017) · Viruses · doi:10.3390/v9070165 · Cited by 38
“Neonatal rodents were found to have strong susceptibility to Chikungunya virus [43], Arenavirus [44], Borna disease virus (BDV) [45], etc.”
BackgroundRole of Dendritic Cells in Viral Brain Infections
Constant, O., Maarifi, G., Blanchet, F. P., Van de Perre, P., Simonin, Y., & Salinas, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.862053 · Cited by 35
AGPAT1 is a novel Chikungunya virus receptor on human cells
Basu, B., Sarmadhikari, D., Sharma, A., Asthana, S., Kalia, M., & Vrati, S. (2026) · Journal of Virology · doi:10.1128/jvi.01733-25
Metadata
- Authors
- Couderc, T., Chrétien, F., Schilte, C., Disson, O., Brigitte, M., Guivel-Benhassine, F., Touret, Y., Barau, G., Cayet, N., Schuffenecker, I., Desprès, P., Arenzana-Seisdedos, F., Michault, A., Albert, M. L., & Lecuit, M.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-02-15
- Volume
- 4
- Issue
- 2
- Pages
- e29
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W1993712001
- Cited by
- 620
- References
- 29
- FWCI
- 28.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.